If you say a health product costs $10, the fee to the industry currently represents 1ยข of that $10. What would happen? As I said, globally, we know others are charging 100% cost recovery and much larger fees, and there has been no negative impact on industry that we know of externally.
In fact, the fees were set quite low in Canada in the 1990s to be sympathetic to the challenges of the industry and to make sure that these didn't cause deleterious economic impacts. We don't know what the impact would be of raising the fees substantially. That would be subject to analysis and discussion with the stakeholders to talk about what the regulatory impact analysis would show.